Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer

Margherita Correnti; Chiara Raggi

doi:10.18632/oncotarget.12569

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer

Margherita Correnti and Chiara Raggi _

PDF | HTML | How to cite

Oncotarget. 2017; 8:7094-7115. https://doi.org/10.18632/oncotarget.12569

Metrics: PDF 2717 views | HTML 2903 views | ?

Abstract

Margherita Correnti1 and Chiara Raggi1

1 Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy

Correspondence to:

Chiara Raggi, email:

Keywords: circulating tumor cells, primary liver cancer, cancer stem cells

Received: August 20, 2016 Accepted: October 04, 2016 Published: October 11, 2016

Abstract

Poor prognosis and high recurrence remain leading causes of primary liver cancer–associated mortality. The spread of circulating tumor cells (CTCs) in the blood plays a major role in the initiation of metastasis and tumor recurrence after surgery. Nevertheless, only a subset of CTCs can survive, migrate to distant sites and establish secondary tumors. Consistent with cancer stem cell (CSC) hypothesis, stem-like CTCs might represent a potential source for cancer relapse and distant metastasis. Thus, identification of stem-like metastasis-initiating CTC-subset may provide useful clinically prognostic information. This review will emphasize the most relevant findings of CTCs in the context of stem-like biology associated to liver carcinogenesis. In this view, the emerging field of stem-like CTCs may deliver substantial contribution in liver cancer field in order to move to personalized approaches for diagnosis, prognosis and therapy.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12569

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer

Abstract